Personal information

Activities

Collapse all

Works (5)

The effects of acute versus repeated cannabidiol administration on trauma‐relevant emotional reactivity: A double‐blind, randomized, placebo‐controlled trial

Journal of Traumatic Stress
2024-12 | Journal article
DOI: 10.1002/jts.23072
Contributors: L. Riley Gournay; Morgan L. Ferretti; Anna‐Marie Nguyen; Sarah Bilsky; Grant S. Shields; Eric Mann; Parker Williams; Sydney Woychesin; Marcel Bonn‐Miller; Ellen W. Leen‐Feldner
Source: check_circle
Crossref

A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects

Cannabis and Cannabinoid Research
2024-10-01 | Journal article
DOI: 10.1089/can.2023.0143
Contributors: Morgan L. Ferretti; L. Riley Gournay; Mia G. Bingaman; Ellen W. Leen-Feldner
Source: check_circle
Crossref

Cannabidiol (CBD) Products: Use Patterns and Perceptions Within a Sample of Anxious Users

Substance Use & Misuse
2024-09-18 | Journal article
DOI: 10.1080/10826084.2024.2369153
Contributors: L. Riley Gournay; Morgan L. Ferretti; Ivori Zvorsky; Daniella A. Fernandez; Ellen W. Leen-Feldner
Source: check_circle
Crossref

Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study

Cannabis and Cannabinoid Research
2024-08-01 | Journal article
DOI: 10.1089/can.2022.0317
Contributors: L. Riley Gournay; Jordan Petry; Sarah Bilsky; Morgan A. Hill; Matthew Feldner; Erica Peters; Marcel Bonn-Miller; Ellen Leen-Feldner
Source: check_circle
Crossref

The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial

Psychopharmacology
2023-10 | Journal article
DOI: 10.1007/s00213-023-06437-0
Contributors: L. Riley Gournay; Morgan L. Ferretti; Sarah Bilsky; Emily Vance; Anna Marie Nguyen; Eric Mann; Parker Williams; Ellen W. Leen-Feldner
Source: check_circle
Crossref

Peer review (2 reviews for 1 publication/grant)

Review activity for Experimental and clinical psychopharmacology. (2)
How many people are using ORCID?